These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 15643424

  • 21. Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way.
    Lerdrup M, Hommelgaard AM, Grandal M, van Deurs B.
    J Cell Sci; 2006 Jan 01; 119(Pt 1):85-95. PubMed ID: 16352662
    [Abstract] [Full Text] [Related]

  • 22. ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
    Dote H, Cerna D, Burgan WE, Camphausen K, Tofilon PJ.
    Cancer Res; 2005 Aug 01; 65(15):6967-75. PubMed ID: 16061682
    [Abstract] [Full Text] [Related]

  • 23. Structural studies on the co-chaperone Hop and its complexes with Hsp90.
    Onuoha SC, Coulstock ET, Grossmann JG, Jackson SE.
    J Mol Biol; 2008 Jun 13; 379(4):732-44. PubMed ID: 18485364
    [Abstract] [Full Text] [Related]

  • 24. ErbB2 degradation mediated by the co-chaperone protein CHIP.
    Zhou P, Fernandes N, Dodge IL, Reddi AL, Rao N, Safran H, DiPetrillo TA, Wazer DE, Band V, Band H.
    J Biol Chem; 2003 Apr 18; 278(16):13829-37. PubMed ID: 12574167
    [Abstract] [Full Text] [Related]

  • 25. p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90.
    Miyata Y, Yahara I.
    Oncogene; 2000 Mar 09; 19(11):1477-84. PubMed ID: 10723140
    [Abstract] [Full Text] [Related]

  • 26. Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2.
    Xu W, Mimnaugh EG, Kim JS, Trepel JB, Neckers LM.
    Cell Stress Chaperones; 2002 Jan 09; 7(1):91-6. PubMed ID: 11892991
    [Abstract] [Full Text] [Related]

  • 27. Heat shock protein 90 regulates development in Dictyostelium discoideum.
    Sawarkar R, Roy N, Rao S, Raman S, Venketesh S, Suguna K, Tatu U.
    J Mol Biol; 2008 Oct 31; 383(1):24-35. PubMed ID: 18718841
    [Abstract] [Full Text] [Related]

  • 28. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
    Prince TL, Kijima T, Tatokoro M, Lee S, Tsutsumi S, Yim K, Rivas C, Alarcon S, Schwartz H, Khamit-Kush K, Scroggins BT, Beebe K, Trepel JB, Neckers L.
    PLoS One; 2015 Oct 31; 10(10):e0141786. PubMed ID: 26517842
    [Abstract] [Full Text] [Related]

  • 29. Heat shock protein 90 stabilization of ErbB2 expression is disrupted by ATP depletion in myocytes.
    Peng X, Guo X, Borkan SC, Bharti A, Kuramochi Y, Calderwood S, Sawyer DB.
    J Biol Chem; 2005 Apr 01; 280(13):13148-52. PubMed ID: 15671027
    [Abstract] [Full Text] [Related]

  • 30. Analysis of conformational determinants underlying HSP90-kinase interaction.
    Kancha RK, Bartosch N, Duyster J.
    PLoS One; 2013 Apr 01; 8(7):e68394. PubMed ID: 23844194
    [Abstract] [Full Text] [Related]

  • 31. Exposure of protein kinase motifs that trigger binding of Hsp90 and Cdc37.
    Prince T, Matts RL.
    Biochem Biophys Res Commun; 2005 Dec 23; 338(3):1447-54. PubMed ID: 16269130
    [Abstract] [Full Text] [Related]

  • 32. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
    Moser C, Lang SA, Stoeltzing O.
    Anticancer Res; 2009 Jun 23; 29(6):2031-42. PubMed ID: 19528462
    [Abstract] [Full Text] [Related]

  • 33. Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation.
    Yun BG, Matts RL.
    Cell Signal; 2005 Dec 23; 17(12):1477-85. PubMed ID: 15935620
    [Abstract] [Full Text] [Related]

  • 34. Interaction of neuropeptide Y and Hsp90 through a novel peptide binding region.
    Ishiwatari-Hayasaka H, Maruya M, Sreedhar AS, Nemoto TK, Csermely P, Yahara I.
    Biochemistry; 2003 Nov 11; 42(44):12972-80. PubMed ID: 14596612
    [Abstract] [Full Text] [Related]

  • 35. The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome.
    Imai J, Maruya M, Yashiroda H, Yahara I, Tanaka K.
    EMBO J; 2003 Jul 15; 22(14):3557-67. PubMed ID: 12853471
    [Abstract] [Full Text] [Related]

  • 36. Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
    Chiosis G, Caldas Lopes E, Solit D.
    Curr Opin Investig Drugs; 2006 Jun 15; 7(6):534-41. PubMed ID: 16784024
    [Abstract] [Full Text] [Related]

  • 37. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
    Ge J, Normant E, Porter JR, Ali JA, Dembski MS, Gao Y, Georges AT, Grenier L, Pak RH, Patterson J, Sydor JR, Tibbitts TT, Tong JK, Adams J, Palombella VJ.
    J Med Chem; 2006 Jul 27; 49(15):4606-15. PubMed ID: 16854066
    [Abstract] [Full Text] [Related]

  • 38. Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin.
    Kumar R, Musiyenko A, Barik S.
    Mol Biochem Parasitol; 2005 May 27; 141(1):29-37. PubMed ID: 15811524
    [Abstract] [Full Text] [Related]

  • 39. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors.
    Powers MV, Workman P.
    Endocr Relat Cancer; 2006 Dec 27; 13 Suppl 1():S125-35. PubMed ID: 17259553
    [Abstract] [Full Text] [Related]

  • 40. Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition.
    Xu W, Soga S, Beebe K, Lee MJ, Kim YS, Trepel J, Neckers L.
    Br J Cancer; 2007 Sep 17; 97(6):741-4. PubMed ID: 17712310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.